Dr. Reddy's Laboratories Limited

RDY | NYSE

Price Alert Chart Builder DCF Calculator

$12.40

+$0.21 (+1.72%)

At close: Sep 21, 2026, 4:00 PM ET

$12.51

+$0.11 (+0.89%)

Pre-market: Sep 22, 2026, 5:26 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $10.15B

Enterprise Value $954.8B

Beta 0.25

Average Volume 2.65M

Shares Outstanding (Diluted) 832.67M

Shares Change YoY -0.04%

Institutional Ownership 14.47%

Exchange NYSE

ISIN US2561352038

Price Performance

Price Change 1M 1.3%

Price Change 3M -13.3%

Price Change 6M -10.6%

Price Change YTD -10.5%

Price Change 1Y -15.1%

Price Change 3Y -6.8%

Price Change 5Y -4.4%

1M CAGR (ann.) 0.7%

1Y CAGR (ann.) -17.1%

5Y CAGR (ann.) -0.8%

All-Time CAGR 8.3%

Valuation

PE Ratio 28.20

Forward PE 27.29

PEG Ratio -0.73

Forward PEG 0.93

PS Ratio 2.81

Forward PS 2.80

PB Ratio 2.61

P/FCF Ratio 38.53

P/Adj. FCF Ratio 38.91

P/OCF Ratio 23.49

EV/Sales 2.87

EV/EBIT 23.97

EV/EBITDA 17.17

EV/FCF 39.36

Earnings Yield 3.4%

FCF Yield 2.5%

Adj. FCF Yield 2.4%

Financial Health

Net Cash ₹10.27B

Total Debt ₹75.81B

Cash & Short-Term Investments ₹86.08B

Total Assets ₹567.88B

Current Ratio 1.90

Quick Ratio 1.39

Debt / Equity Ratio 0.19

Debt / EBITDA 1.36

Debt / FCF 3.13

OCF / Debt 0.75

Interest Coverage 8.47

Altman Z-Score 4.89

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 50.2%

Operating Profit Margin 10.6%

EBITDA Margin 20.1%

Net Profit Margin 10.0%

FCF Margin 7.3%

Adj. FCF Margin 7.2%

SBC / Revenue 0.1%

SBC Impact (per share) -1.0%

Returns

Return on Assets 5.8%

Return on Equity 8.9%

Return on Invested Capital 5.8%

Return on Capital Employed 8.4%

Return on Tangible Assets 7.2%

Historical Growth (CAGR)

Revenue CAGR 3Y 34.5%

Revenue CAGR 5Y 27.2%

Revenue CAGR 10Y 8.3%

EPS CAGR 3Y -48.0%

EPS CAGR 5Y -19.1%

EPS CAGR 10Y -7.6%

FCF CAGR 3Y -15.4%

FCF CAGR 5Y 9.0%

FCF CAGR 10Y -0.8%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 20.3%

Revenue Growth Next 3Y 9.0%

Earnings Date Oct 22, 2026

EPS Estimate (next Q) $0

EPS Growth Est (next Q) -48.4%

Revenue Est (next Q) $8.8M

Revenue Growth Est (next Q) -15.8%

Fair Value Estimates

Graham Number $6.90

Graham Upside -44.4%

Lynch Fair Value $2.20

Lynch Upside -82.3%

Price Target N/A

Price Target Upside N/A

Cash Flow

Operating Cash Flow ₹56.55B

Free Cash Flow ₹24.26B

Adj. Free Cash Flow ₹24.02B

FCF Per Share $17.66

OCF Per Share $47.78

OCF/S Ratio 12.0%

Income Statement

Revenue ₹332.83B

Gross Profit ₹166.92B

Operating Income ₹35.2B

EBITDA ₹55.6B

Net Income ₹33.17B

EPS (Diluted) $39.80

Revenue / Employee $12.09M

Profit / Employee $1.2M

Employees 27,527

Dividends

Annual Dividend $0.08

Dividend Yield 0.65%

Payout Ratio 0.2%

FCF Payout Ratio 27.3%

Adj. FCF Payout Ratio 27.6%

Dividend Growth (YoY) -8.9%

Pay Frequency Annual

Ex-Dividend Date Jul 23, 2026